All Stories

  1. Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study

    Article • Diabetes Care, March 2021, American Diabetes Association

    Johan Bodegard

  2. Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study

    Article • Endocrinology Diabetes & Metabolism, August 2018, Wiley

    Johan Bodegard, Dr Frederik Persson

  3. Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

    Article • Diabetes Obesity and Metabolism, April 2018, Wiley

    Johan Bodegard

  4. Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study

    Article • Diabetes Obesity and Metabolism, September 2017, Wiley

    Johan Bodegard, Dr Frederik Persson